BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18054006)

  • 1. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis.
    Nandan MO; McConnell BB; Ghaleb AM; Bialkowska AB; Sheng H; Shao J; Babbin BA; Robine S; Yang VW
    Gastroenterology; 2008 Jan; 134(1):120-30. PubMed ID: 18054006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
    Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
    Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
    Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL
    Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.
    Nandan MO; Yoon HS; Zhao W; Ouko LA; Chanchevalap S; Yang VW
    Oncogene; 2004 Apr; 23(19):3404-13. PubMed ID: 15077182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
    Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
    Ji Z; Mei FC; Xie J; Cheng X
    J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible intestine-specific deletion of Krüppel-like factor 5 is characterized by a regenerative response in adult mouse colon.
    Nandan MO; Ghaleb AM; Liu Y; Bialkowska AB; McConnell BB; Shroyer KR; Robine S; Yang VW
    Dev Biol; 2014 Mar; 387(2):191-202. PubMed ID: 24440658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells.
    Chanchevalap S; Nandan MO; McConnell BB; Charrier L; Merlin D; Katz JP; Yang VW
    Nucleic Acids Res; 2006; 34(4):1216-23. PubMed ID: 16500892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-Ras
    Nandan MO; Bialkowska AB; Yang VW
    Am J Cancer Res; 2018; 8(4):723-731. PubMed ID: 29736317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-Like Factor 5 Promotes Epithelial Proliferation and DNA Damage Repair in the Intestine of Irradiated Mice.
    Li M; Gu Y; Ma YC; Shang ZF; Wang C; Liu FJ; Cao JP; Wan HJ; Zhang XG
    Int J Biol Sci; 2015; 11(12):1458-68. PubMed ID: 26681925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüpple-like factor 5 is required for proper maintenance of adult intestinal crypt cellular proliferation.
    Bell KN; Shroyer NF
    Dig Dis Sci; 2015 Jan; 60(1):86-100. PubMed ID: 25069574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screening.
    Bialkowska AB; Crisp M; Bannister T; He Y; Chowdhury S; Schürer S; Chase P; Spicer T; Madoux F; Tian C; Hodder P; Zaharevitz D; Yang VW
    Mol Cancer Ther; 2011 Nov; 10(11):2043-51. PubMed ID: 21885866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
    Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal tumor progression is associated with altered function of KLF5.
    Bateman NW; Tan D; Pestell RG; Black JD; Black AR
    J Biol Chem; 2004 Mar; 279(13):12093-101. PubMed ID: 14726538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening.
    Bialkowska AB; Du Y; Fu H; Yang VW
    Mol Cancer Ther; 2009 Mar; 8(3):563-70. PubMed ID: 19240162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection.
    McConnell BB; Klapproth JM; Sasaki M; Nandan MO; Yang VW
    Gastroenterology; 2008 Apr; 134(4):1007-16. PubMed ID: 18395082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS-mediated up-regulation of RRM2 expression is essential for the proliferation of colorectal cancer cell lines.
    Yoshida Y; Tsunoda T; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Takashima Y; Sasazuki T; Kuroki M; Iwasaki A; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2535-9. PubMed ID: 21873171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Kruppel-like factor 5.
    Chanchevalap S; Nandan MO; Merlin D; Yang VW
    FEBS Lett; 2004 Dec; 578(1-2):99-105. PubMed ID: 15581624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krüppel-like factor 5 is essential for maintenance of barrier function in mouse colon.
    Liu Y; Chidgey M; Yang VW; Bialkowska AB
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G478-G491. PubMed ID: 28864500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF5 regulates the integrity and oncogenicity of intestinal stem cells.
    Nakaya T; Ogawa S; Manabe I; Tanaka M; Sanada M; Sato T; Taketo MM; Nakao K; Clevers H; Fukayama M; Kuroda M; Nagai R
    Cancer Res; 2014 May; 74(10):2882-91. PubMed ID: 24626089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.